KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Novavax (NVAX) Cost of Revenue (2022 - 2025)

Novavax has reported Cost of Revenue over the past 9 years, most recently at $22.1 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $22.1 million for Q4 2025, down 39.72% from a year ago — trailing twelve months through Dec 2025 was $73.0 million (down 63.97% YoY), and the annual figure for FY2025 was $73.0 million, down 63.97%.
  • Cost of Revenue for Q4 2025 was $22.1 million at Novavax, up from $21.5 million in the prior quarter.
  • Over the last five years, Cost of Revenue for NVAX hit a ceiling of $434.6 million in Q3 2022 and a floor of $14.1 million in Q1 2025.
  • Median Cost of Revenue over the past 4 years was $51.0 million (2023), compared with a mean of $95.1 million.
  • Peak annual rise in Cost of Revenue hit 124.19% in 2023, while the deepest fall reached 79.42% in 2023.
  • Novavax's Cost of Revenue stood at $181.8 million in 2022, then decreased by 14.74% to $155.0 million in 2023, then plummeted by 76.34% to $36.7 million in 2024, then plummeted by 39.72% to $22.1 million in 2025.
  • The last three reported values for Cost of Revenue were $22.1 million (Q4 2025), $21.5 million (Q3 2025), and $15.3 million (Q2 2025) per Business Quant data.